132 related articles for article (PubMed ID: 7600028)
1. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients.
Tammilehto L; Kivisaari L; Salminen US; Maasilta P; Mattson K
Lung Cancer; 1995 Mar; 12(1-2):25-34. PubMed ID: 7600028
[TBL] [Abstract][Full Text] [Related]
2. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
Rusch VW; Venkatraman E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
[TBL] [Abstract][Full Text] [Related]
3. The Prognostic Role of TNM Staging Compared With Tumor Volume and Number of Pleural Sites in Malignant Pleural Mesothelioma.
Proto C; Signorelli D; Mallone S; Prelaj A; Lo Russo G; Imbimbo M; Galli G; Ferrara R; Ganzinelli M; Leuzzi G; Greco FG; Calareso G; Botta L; Gatta G; Garassino M; Trama A
Clin Lung Cancer; 2019 Nov; 20(6):e652-e660. PubMed ID: 31377142
[TBL] [Abstract][Full Text] [Related]
4. A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.
Rusch VW
Lung Cancer; 1996 Feb; 14(1):1-12. PubMed ID: 8696713
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
[TBL] [Abstract][Full Text] [Related]
6. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
7. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
8. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
Rusch VW
Chest; 1995 Oct; 108(4):1122-8. PubMed ID: 7555126
[TBL] [Abstract][Full Text] [Related]
9. Initial analysis of the international association for the study of lung cancer mesothelioma database.
Rusch VW; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Pass H; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP;
J Thorac Oncol; 2012 Nov; 7(11):1631-9. PubMed ID: 23070243
[TBL] [Abstract][Full Text] [Related]
10. The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging.
Patz EF; Rusch VW; Heelan R
AJR Am J Roentgenol; 1996 Feb; 166(2):323-7. PubMed ID: 8553940
[TBL] [Abstract][Full Text] [Related]
11. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
Mineo TC; Ambrogi V; Pompeo E; Baldi A; Stella F; Aurea P; Marino M
Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
[TBL] [Abstract][Full Text] [Related]
12. Integrated FDG PET-CT imaging improves staging in malignant pleural mesothelioma.
Krüger S; Pauls S; Mottaghy FM; Buck AK; Schelzig H; Hombach V; Reske SN
Nuklearmedizin; 2007; 46(6):239-43. PubMed ID: 18084678
[TBL] [Abstract][Full Text] [Related]
13. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
[TBL] [Abstract][Full Text] [Related]
14. Does positron emission tomography offer prognostic information in malignant pleural mesothelioma?
Sharif S; Zahid I; Routledge T; Scarci M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):806-11. PubMed ID: 21266493
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
Genestreti G; Moretti A; Piciucchi S; Tiseo M; Bersanelli M; Scarlattei M; Scarpi E; Dubini A; Matteucci F; Sanna S
Technol Cancer Res Treat; 2012 Apr; 11(2):163-7. PubMed ID: 22335410
[TBL] [Abstract][Full Text] [Related]
16. Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
Richards WG; Godleski JJ; Yeap BY; Corson JM; Chirieac LR; Zellos L; Mujoomdar A; Jaklitsch MT; Bueno R; Sugarbaker DJ
Cancer; 2010 Mar; 116(6):1510-7. PubMed ID: 20108310
[TBL] [Abstract][Full Text] [Related]
17. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
Gill RR; Yeap BY; Bueno R; Richards WG
J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
[TBL] [Abstract][Full Text] [Related]
19. A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Rusch VW; Gill R; Mitchell A; Naidich D; Rice DC; Pass HI; Kindler HL; De Perrot M; Friedberg J;
Ann Thorac Surg; 2016 Oct; 102(4):1059-66. PubMed ID: 27596916
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
